Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Dysbiosis × Esomeprazole × Clear all

Phase

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Stomach Neoplasms 7 Barrett Esophagus 7 Gastritis 5 Breast Neoplasms 4 Stomach Ulcer 3 Peptic Ulcer 3 Gastroesophageal Reflux 3 Dyspepsia 3 Zollinger-Ellison Syndrome 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Vomiting 1 Radiation Esophagitis 1 Precancerous Conditions 1 Peptic Ulcer Hemorrhage 1 Neoplasm Metastasis 1 Nausea 1 Multiple Endocrine Neoplasia Type 1 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1 Hot Flashes 1 Hemorrhage 1 Head and Neck Neoplasms 1 Gastrointestinal Stromal Tumors 1 Gastritis Dyspepsia Helicobacter Pylori Infection Gastric Cancer Peptic Ulcer 1 Esophagitis, Peptic 1 Esophagitis 1 Dysbiosis 1 Colonic Neoplasms 1 Advanced Non-small Cell Lung Cancer 1

Interventions

bismuth tripotassium dicitrate 1 Tetracycline 1 Tablets 1 Observation 1 Metronidazole 1 Lacteol 1 Esomeprazole 1 Colonoscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04527055 2024-06-24

Bsm10

National Cheng-Kung University Hospital

Phase 4 Enrolling by invitation

Dysbiosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡